CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Tandem Diabetes Care, Inc. recalls t:slim X2 Insulin Pump with…

Tandem Diabetes Care, Inc. recalls t:slim X2 Insulin Pump with Interoperable Technology and 1 more

Read the official FDA notice

Published
23 Apr 2025
Units affected
2 products
Agency
FDA
Country
United States

The hazard

A software defect in Version 7.9 of the pump software for Tandem t:slim X2 and Tandem Mobi pumps, when used with Control IQ+ technology, will cause the pump to incorrectly interpolate glucose trends when the Estimated Glucose Value (EGV) is above 255 mg/dL at the start or end of a gap in data collection due to a lapse in connection from a paired continuous glucose monitor (CGM) sensor, which can lead to under-delivery or over-delivery of insulin based on inaccurate result leading to severe cases of hypoglycemia or hyperglycemia.

Classification: Class I — the most serious type: there is a reasonable chance this product could cause serious health problems or death.

What to do

Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.

  • Check the model and lot or serial number on the device label.
  • Speak to your doctor or the clinic that supplied the device before stopping use.
Read the official FDA notice

Product details

t:slim X2 Insulin Pump with Interoperable Technology

Tandem Mobi Insulin Pump with Interoperable Technology

Brand / company
Tandem Diabetes Care, Inc.
Codes / lots
Software versions 7.9/UDI: 00389152407012 | Software versions 7.9/UDI: 00389152480114
Distribution
US: AZ, CA, CO, CT, FL, HI, IA, ID, IL, IN, MD, ME, MI, MO, MS, NC, ND, NE, NJ, NM, NV, NY, OH, PA, TX, UT, VA, WA, WI OUS: N/A
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 23 Apr 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.